Search Results

US Study Says Third Course of Radiation Therapy May Improve Survival and Symptoms in Children with Recurrent DIPG

According to news from the Icahn School of Medicine at Mount Sinai in the United States on September 2, researchers at the institution released a new study on re-irradiation for recurrent diffuse intrinsic pontine glioma (DIPG). The study shows that carefully selected pediatric patients who receive a third course of radiation therapy after disease recurrence may achieve symptom relief, improved quality of life, and potentially prolonged survival. The related study has been published in Practical Radiation Oncology. DIPG is a highly aggressive pediatric brain tumor that occurs in the brainstem region. The brainstem controls critical life functions such as breathing and movement, so the tumor usually cannot be removed surgically. Data show that DIPG mainly affects children aged 5 to 10, and even...

2026-09-10

India's Fortis Healthcare Plans to Introduce the Country's First Upright Proton Therapy System

India's Fortis Healthcare has announced plans to install Mevion Medical Systems' MEVION S250-FIT proton therapy system at Fortis Memorial Research Institute (FMRI) in Gurugram. The hospital is Fortis' flagship quaternary care hospital and its comprehensive oncology and precision cancer treatment center. According to reports, the system will be equipped with Leo Cancer Care's Marie® upright patient positioning and imaging solution, as well as RaySearch Laboratories' RayStation® treatment planning software. If the project receives relevant regulatory approvals and completes site preparation, Fortis will become India's first planned...

2026-09-10

Hyogo Medical University Hospital to Launch Japan's First Elekta Evo Linear Accelerator System Treatments

Elekta K.K. announced on August 27 that its high-precision radiation therapy device, the Elekta Evo linear accelerator system, will be installed for the first time in Japan at Hyogo Medical University Hospital, with the first treatment scheduled to commence on September 24, 2026. This marks the entry of this next-generation radiation therapy system into clinical application in Japan. As the number of cancer patients increases, the demand for personalized and precise treatment in the field of radiation therapy continues to rise. The Elekta Evo is positioned as a next-generation radiation therapy system capable of covering both routine and more complex cancer treatment scenarios. The system is equipped with Iris, an AI-driven high-definition imaging technology, which enables clearer visualization of the positional relationships between organs in the patient's body...

2026-08-27

Korea's Gil Medical Center Expands Application of Markerless Surface-Guided Radiation Therapy

Gachon University Gil Medical Center in South Korea announced on August 26 that it is expanding the clinical application of markerless surface-guided radiation therapy (SGRT) to enhance the precision and comfort of radiation therapy for cancer patients. According to the hospital, the proportion of markerless SGRT in its radiation therapy procedures has increased from 28% in the first half of 2025 to 37% in the first half of 2026. This change indicates that this treatment-assistive technology, which reduces the burden of skin marking on patients, is gaining broader clinical adoption. Markerless SGRT is an advanced technique used for patient positioning and monitoring during radiation therapy. Unlike conventional methods, patients do not need to retain target line markings on their skin; the treatment system can assist in confirming patient positioning through surface guidance, enabling radiation to be delivered more accurately to the target area.

2026-08-26

South Korean team develops biodegradable microgel for localized radiation therapy

Pusan National University announced on August 25 that a research team led by Professor Yang Seung-yun from the Department of Biomaterials Science, in collaboration with Professor Kim Hoon-soo from the Department of Dermatology and Professor Kim Geun-young from the Department of Nuclear Medicine at Pusan National University Hospital, as well as SNBIA Co., Ltd., has developed a precision localized radiation therapy technology based on biodegradable radioactive isotope materials for the treatment of refractory keloids that tend to recur after surgery. Conceptual diagram of precision treatment technology for refractory keloids. Provided by Pusan National University. Keloids are caused by abnormal proliferation of fibroblasts and excessive accumulation of collagen after skin injury. Existing treatment methods include surgery, steroid injections, laser therapy, etc., but...

2026-08-25

Former U.S. President Biden's Prostate Cancer Progress: Has Received Radiation Therapy and Hormone Therapy

The health condition of former U.S. President Joe Biden has recently drawn renewed attention. In an interview video, his son Hunter Biden stated that after Biden was diagnosed with prostate cancer, the cancer cells had metastasized, spreading to the bones and other parts of the body, and described the process as extremely painful. According to relevant information, Biden, now 83 years old, disclosed in May 2025 that he had been diagnosed with an aggressive form of prostate cancer, with cancer cells confirmed to have spread to the bones at that time. In October, a Biden spokesperson announced that he was undergoing radiation therapy and hormone therapy. Radiation therapy is one of the common nuclear technology medical applications in tumor treatment, primarily using ionizing radiation on tumor tissue to...

2026-08-10

Samsung and Accuray Plan Collaboration on Image-Guided Precision Radiation Therapy

Samsung Electronics' medical device business and Samsung Medison continue to shift their business focus from medical diagnostics to treatment. On August 5, Samsung HME America and U.S. radiosurgery company Accuray announced the signing of a non-binding letter of intent to explore collaboration on volume imaging-based precision radiation therapy solutions. Under the letter of intent, the two parties plan to study the integration of Samsung's mobile CT scanner BodyTom with Accuray's robotic radiosurgery platform CyberKnife. This collaboration direction aims to connect high-resolution 3D imaging capabilities with image-guided robotic radiosurgery technology, enabling medical staff to more accurately identify...

2026-08-05

US Intermountain Health Opens New Outpatient Clinic in Las Vegas, Equipped with PET/CT and Linear Accelerator

Intermountain Health, headquartered in Salt Lake City, recently opened a new outpatient clinic in southwest Las Vegas. Named Badura Clinic, the facility spans approximately 90,000 square feet and is located in the Spring Valley area, marking the health system's first new construction project in Nevada. The three-story Badura Clinic officially opened following a ribbon-cutting ceremony and community open house on July 30. The clinic consolidates primary care and select specialty services previously dispersed across multiple locations in the Las Vegas Valley, offering more centralized medical care for children, adults, and senior patients. According to the introduction, the clinic's services include adult and...

2026-08-05

Enzychem Lifesciences Signs MOU with Korea Institute of Radiological & Medical Sciences to Jointly Develop Radiation-Induced Dermatitis Treatment

Enzychem Lifesciences announced on August 4 that it has signed a Memorandum of Understanding (MOU) with the Korea Institute of Radiological & Medical Sciences (KIRAMS) for joint research on a treatment for radiation-induced dermatitis. Based on their respective research capabilities and expertise, the two parties will explore the feasibility of developing a treatment for radiation-induced dermatitis and advance joint new drug research. Radiation-induced dermatitis is one of the most common treatment-related side effects in cancer patients undergoing radiation therapy, manifesting as skin erythema, pain, itching, and peeling. In severe cases, it can delay or interrupt radiotherapy schedules, not only reducing patients' quality of life but also negatively affecting the treatment process. The treatment has recently...

2026-08-04

Kangbuk Samsung Hospital in South Korea Validates Precision of New-Generation Surface-Guided Radiation Therapy System

The research team from the Department of Radiation Oncology at Kangbuk Samsung Hospital in South Korea announced on July 31 that they have completed validation of the geometric accuracy and respiratory tracking performance of a new-generation surface-guided radiation therapy system. The research findings have been published in the latest issue of the international academic journal *Radiation Physics and Chemistry*. In breast cancer radiotherapy, the deep inspiration breath-hold technique is commonly used in clinical practice to reduce radiation exposure to the heart and lungs. Traditional procedures typically require tattoo marks or drawn guide lines on the patient's skin surface, along with wearing sensors to monitor respiratory motion, which somewhat compromises treatment convenience and patient comfort. The new-generation surface-guided radiation therapy system validated in this study utilizes 3D stereoscopic cameras and thermal imaging technology...

2026-08-02